benefits and side effects of glp 1 GLP-1 are common—You don't have to live with them glp 1 benefits and side

NICE Technology Appraisal guidance (TA875 for semaglutide/Wegovy and TA664 for liraglutide/Saxenda) recommends these medications for weight management in adults with: A body mass index (BMI) of at least 35 kg/m and At least one weight-related comorbidity (such as type 2 diabetes, hypertension, dyslipidaemia, obstructive sleep apnoea, or non-alcoholic fatty liver disease) For liraglutide (Saxenda), NICE TA664 specifies additional criteria including prediabetes (HbA1c 42-47 mmol/mol or fasting plasma glucose 5.5-6.9 mmol/L) or high risk of cardiovascular disease

Therapeutic management of metabolic dysfunction associated steatotic liver disease

GEPRFTE QUALITT

From a clinical perspective, the love handle region can be considered an acceptable injection site if it contains adequate subcutaneous tissue and meets the standard requirements for subcutaneous injection